Under-representation of elderly in clinical trials: An analysis of the initial approval documents in the Food and Drug Administration database.

25 January 2019. doid: 10.1111/bcp.13876

Ruiter R, Burggraaf J, Rissmann R

To evaluate the availability of pharmacokinetic, safety and efficacy analyses specifically targeted at elderly, prior to the authorization of drugs.